These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 6662804)
1. Studies on peptide antibiotics, leucinostatins. I. Separation, physico-chemical properties and biological activities of leucinostatins A and B. Fukushima K; Arai T; Mori Y; Tsuboi M; Suzuki M J Antibiot (Tokyo); 1983 Dec; 36(12):1606-12. PubMed ID: 6662804 [TBL] [Abstract][Full Text] [Related]
2. Studies on peptide antibiotics, leucinostatins. II. The structures of leucinostatins A and B. Fukushima K; Arai T; Mori Y; Tsuboi M; Suzuki M J Antibiot (Tokyo); 1983 Dec; 36(12):1613-30. PubMed ID: 6662805 [TBL] [Abstract][Full Text] [Related]
3. Dual inhibitory effects of the peptide antibiotics leucinostatins on oxidative phosphorylation in mitochondria. Shima A; Fukushima K; Arai T; Terada H Cell Struct Funct; 1990 Feb; 15(1):53-8. PubMed ID: 2140298 [TBL] [Abstract][Full Text] [Related]
4. Mycoplanecins, novel antimycobacterial antibiotics from Actinoplanes awajinensis subsp. mycoplanecinus subsp. nov. II. Isolation, physico-chemical characterization and biological activities of mycoplanecin A. Nakajima M; Torikata A; Ichikawa Y; Katayama T; Shiraishi A; Haneishi T; Arai M J Antibiot (Tokyo); 1983 Aug; 36(8):961-6. PubMed ID: 6630066 [TBL] [Abstract][Full Text] [Related]
5. Leucinostatins, peptide mycotoxins produced by Paecilomyces lilacinus and their possible roles in fungal infection. Mikami Y; Fukushima K; Arai T; Abe F; Shibuya H; Ommura Y Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Jul; 257(2):275-83. PubMed ID: 6485630 [TBL] [Abstract][Full Text] [Related]
6. Structure of leucinostatin B, an uncoupler on mitochondria. Mori Y; Suzuki M; Fukushima K; Arai T J Antibiot (Tokyo); 1983 Aug; 36(8):1084-6. PubMed ID: 6630061 [No Abstract] [Full Text] [Related]
7. Clostomicins, new antibiotics produced by Micromonospora echinospora subsp. armeniaca subsp. nov. I. Production, isolation, and physico-chemical and biological properties. Omura S; Imamura N; Oiwa R; Kuga H; Iwata R; Masuma R; Iwai Y J Antibiot (Tokyo); 1986 Oct; 39(10):1407-12. PubMed ID: 3781911 [TBL] [Abstract][Full Text] [Related]
9. Leucinostatins H and K, two novel peptide antibiotics with tertiary amine-oxide terminal group from Paecilomyces marquandii isolation, structure and biological activity. Radics L; Kajtar-Peredy M; Casinovi CG; Rossi C; Ricci M; Tuttobello L J Antibiot (Tokyo); 1987 May; 40(5):714-6. PubMed ID: 3610826 [No Abstract] [Full Text] [Related]
10. Leucinostatin D, a novel peptide antibiotic from Paecilomyces marquandii. Rossi C; Tuttobello L; Ricci M; Casinovi CG; Radics L J Antibiot (Tokyo); 1987 Jan; 40(1):130-3. PubMed ID: 3558114 [No Abstract] [Full Text] [Related]
11. The myxalamids, new antibiotics from Myxococcus xanthus (Myxobacterales). I. Production, physico-chemical and biological properties, and mechanism of action. Gerth K; Jansen R; Reifenstahl G; Höfle G; Irschik H; Kunze B; Reichenbach H; Thierbach G J Antibiot (Tokyo); 1983 Sep; 36(9):1150-6. PubMed ID: 6415031 [TBL] [Abstract][Full Text] [Related]
12. The aurachins, new quinoline antibiotics from myxobacteria: production, physico-chemical and biological properties. Kunze B; Höfle G; Reichenbach H J Antibiot (Tokyo); 1987 Mar; 40(3):258-65. PubMed ID: 3106289 [TBL] [Abstract][Full Text] [Related]
13. Studies on a new nucleoside antibiotic, dapiramicin. II. Isolation, physico-chemical and biological characterization. Nishizawa N; Kondo Y; Koyama M; Omoto S; Iwata M; Tsuruoka T; Inouye S J Antibiot (Tokyo); 1984 Jan; 37(1):1-5. PubMed ID: 6546562 [TBL] [Abstract][Full Text] [Related]
14. Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. IV. Separation and characterization of the components of teichomycin (teicoplanin). Borghi A; Coronelli C; Faniuolo L; Allievi G; Pallanza R; Gallo GG J Antibiot (Tokyo); 1984 Jun; 37(6):615-20. PubMed ID: 6235204 [TBL] [Abstract][Full Text] [Related]
15. [Antibiotics of an aromatic nature from Pseudomonas cepacia]. Smirnov VV; Kiprianova EA; Dodatko TA; Garagulia AD; Kliuev NA Mikrobiol Zh (1978); 1991; 53(5):41-5. PubMed ID: 1724281 [TBL] [Abstract][Full Text] [Related]
16. Cryomycin, a new peptide antibiotic produced only at low temperature. Yoshida N; Tani Y; Ogata K J Antibiot (Tokyo); 1972 Nov; 25(11):653-9. PubMed ID: 4630599 [No Abstract] [Full Text] [Related]
17. Jokipeptin, a new peptide antibiotic. I. Isolation, physico-chemical and biological characteristics. Ito M; Koyama Y J Antibiot (Tokyo); 1972 May; 25(5):304-8. PubMed ID: 5042449 [No Abstract] [Full Text] [Related]
18. New peptide antibiotics LI-F03, F04, F05, F07, and F08, produced by Bacillus polymyxa. I. Isolation and characterization. Kurusu K; Ohba K; Arai T; Fukushima K J Antibiot (Tokyo); 1987 Nov; 40(11):1506-14. PubMed ID: 3693120 [TBL] [Abstract][Full Text] [Related]
20. Crisamicin A, a new antibiotic from Micromonospora. I. Taxonomy of the producing strain, fermentation, isolation, physico-chemical characterization and antimicrobial properties. Nelson RA; Pope JA; Luedemann GM; McDaniel LE; Schaffner CP J Antibiot (Tokyo); 1986 Mar; 39(3):335-44. PubMed ID: 3754547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]